MSH2 Gene Muir-Torre Syndrome NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Cancer Risk
The MSH2 Gene Muir-Torre Syndrome NGS Genetic DNA Test represents a breakthrough in personalized cancer risk assessment. This advanced diagnostic tool utilizes next-generation sequencing technology to analyze the MSH2 gene, which plays a critical role in DNA mismatch repair. When mutations occur in this gene, individuals face significantly elevated risks for developing multiple types of cancer throughout their lifetime.
What Does This Test Measure?
This comprehensive genetic analysis specifically targets the MSH2 gene to identify pathogenic variants that cause Muir-Torre syndrome. The test examines:
- Complete MSH2 gene sequencing for point mutations
- Detection of large deletions and duplications
- Assessment of DNA mismatch repair function
- Identification of inherited cancer predisposition
Who Should Consider This Test?
This genetic screening is particularly recommended for individuals who exhibit:
- Personal history of multiple primary cancers
- Family history of Muir-Torre syndrome
- Diagnosis of sebaceous neoplasms or keratoacanthomas
- Early-onset colorectal cancer (before age 50)
- Multiple family members with Lynch syndrome-related cancers
- Unexplained gastrointestinal or gynecological cancers
Key Benefits of MSH2 Genetic Testing
Undergoing this comprehensive genetic assessment provides numerous advantages:
- Early Cancer Detection: Identify cancer risks before symptoms develop
- Personalized Screening: Tailor cancer surveillance protocols based on genetic risk
- Family Planning: Make informed decisions about genetic inheritance
- Proactive Management: Implement preventive measures and early interventions
- Peace of Mind: Reduce uncertainty about hereditary cancer risks
Understanding Your Test Results
Your genetic test results will fall into one of several categories:
- Positive Result: A pathogenic variant was identified, indicating increased cancer risk and the need for enhanced surveillance
- Negative Result: No known pathogenic variants were detected, though family history remains important
- Variant of Uncertain Significance: A genetic change was found, but its clinical significance is currently unknown
All results are accompanied by comprehensive genetic counseling to ensure proper understanding and appropriate next steps.
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
GGC DNA provides comprehensive genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure accurate and reliable results with a turnaround time of 3-4 weeks.
Take Control of Your Genetic Health Today
Don’t wait to understand your hereditary cancer risks. Our experienced genetic counselors and oncology specialists are ready to guide you through the testing process and help interpret your results. Early detection through genetic testing can save lives and provide valuable information for your entire family.
Call us today at +1(267) 388-9828 to schedule your MSH2 Gene Muir-Torre Syndrome NGS Genetic DNA Test and take the first step toward proactive cancer prevention.
